{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 9
    }
  },
  "results": [
    {
      "update_type": "Reverified",
      "initial_posting_date": "12/18/2020",
      "package_ndc": "63323-771-39",
      "generic_name": "Azacitidine Injection",
      "contact_info": "1-888-386-1300",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "openfda": {
        "application_number": [
          "ANDA207518"
        ],
        "brand_name": [
          "AZACITIDINE"
        ],
        "generic_name": [
          "AZACITIDINE"
        ],
        "manufacturer_name": [
          "Fresenius Kabi USA, LLC"
        ],
        "product_ndc": [
          "63323-771"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS",
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "AZACITIDINE"
        ],
        "rxcui": [
          "485246"
        ],
        "spl_id": [
          "4becda8d-8042-4cf1-bef3-c0ec3c23eebe"
        ],
        "spl_set_id": [
          "3b594aba-e798-4105-b801-0b0d970747c1"
        ],
        "package_ndc": [
          "63323-771-39"
        ],
        "nui": [
          "N0000000233",
          "N0000175595"
        ],
        "pharm_class_moa": [
          "Nucleic Acid Synthesis Inhibitors [MoA]"
        ],
        "pharm_class_epc": [
          "Nucleoside Metabolic Inhibitor [EPC]"
        ],
        "unii": [
          "M801H13NRU"
        ]
      },
      "update_date": "10/15/2026",
      "therapeutic_category": [
        "Oncology"
      ],
      "dosage_form": "Injection",
      "presentation": "Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39)",
      "company_name": "Fresenius Kabi USA, LLC",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "status": "Current"
    }
  ]
}